Tango Therapeutics, Inc. (TNGX) Social Stream



Tango Therapeutics, Inc. (TNGX): $5.07

0.32 (+6.74%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TNGX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Tango Therapeutics Inc (TNGX) Price Targets From Analysts

Use the tables below to see what analysts covering Tango Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-11 3 $25 $16 $20.333 $7.49 171.47%
2022-03-29 3 $20 $14 $16.666 $7.49 122.51%

Over the past 28 weeks, TNGX's average upside potential has been 45.16%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-11 NA 20 16 17.750 15.59 13.86%
2021-09-18 NA 20 16 17.750 17.30 2.6%
2021-09-20 4 20 16 17.750 16.60 6.93%
2021-11-11 3 25 16 20.333 12.97 56.77%
2022-03-29 3 20 14 16.666 7.15 133.09%

TNGX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


TNGX's average broker recommendation rating improved by 0 over the prior 120 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • TNGX has a higher number of analysts covering the stock than 22.28% of all US stocks.
  • TNGX has a greater upside potential (average analyst target price relative to current price) than 166.72% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, Tango Therapeutics Inc's average analyst price target is greater than 41.48% of them.
  • In the context of Pharmaceutical Products stocks, Tango Therapeutics Inc's variance in analysts' estimates is lower than 34.33% of them.

Stocks similar to Tango Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are THTX, THRX, and THRN.

What is the outlook for TNGX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4915 seconds.